| 1331638 | COPD14_H | Chronic obstructive pulmonary disease QTL 14 (human) | 1.5 | | Chronic airflow obstruction | post-BD FEV1 minus pre-BD FEV1 | 3 | 36484119 | 175785038 | Human |
| 1331643 | COPD16_H | Chronic obstructive pulmonary disease QTL 16 (human) | 1.07 | | Chronic airflow obstruction | post-BD FEV1 minus pre-BD FEV1/pre-BD FEV1 x 100 | 3 | 49418084 | 197953164 | Human |
| 1576347 | COARD3_H | Coronary artery disease susceptibility QTL 3 (human) | 2.42 | | Coronary artery disease susceptibility | early-onset | 3 | 73258381 | 132686410 | Human |
| 1576344 | COARD1_H | Coronary artery disease susceptibility QTL 1 (human) | 3.5 | .001 | Coronary artery disease susceptibility | early-onset | 3 | 73258381 | 139188599 | Human |
| 1576333 | COARD2_H | Coronary artery disease susceptibility QTL 2 (human) | 3.16 | | Coronary artery disease susceptibility | early-onset | 3 | 73258381 | 139188599 | Human |
| 1298479 | RA5_H | Rheumatoid arthritis QTL 5 (human) | | .0288 | Joint/bone inflammation | rheumatoid arthritis | 3 | 107892192 | 133892192 | Human |
| 2292832 | PRSTS8_H | Prostate tumor susceptibility QTL 8 (human) | | | Prostate tumor susceptibility | early onset | 3 | 107892192 | 133892192 | Human |
| 2315774 | GLUCO143_H | Glucose level QTL 143 (human) | 2.06 | .0019 | Glucose level | | 3 | 118630446 | 144630446 | Human |
| 1300030 | BW23_H | Body weight QTL 23 (human) | 3.45 | | Body weight | body mass index | 3 | 126188483 | 152188483 | Human |
| 1643083 | BW122_H | Body Weight QTL 122 (human) | 2.61 | .00027 | Body weight | | 3 | 126188483 | 152188483 | Human |
| 1643436 | SLIPL10_H | Serum lipid level QTL 10 (human) | 1.83 | .002 | Lipid level | | 3 | 126188483 | 152188483 | Human |
References - curated
